Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has emerged as a global pandemic that upended existing protocols and practices, including those for allogeneic hematopoietic stem cell transplantation (HCT). Here, we describe the su...

Descripción completa

Detalles Bibliográficos
Autores principales: Pourhassan, Hoda, La Rosa, Corinna, Chiuppesi, Flavia, Puing, Alfredo, Aldoss, Ibrahim, Park, Yoonsuh, Zhou, Qiao, Karpinski, Veronica, Faircloth, Katelyn, Kaltcheva, Teodora, Johnson, Daisy, Francisco, Sandra Ortega, Zaia, John A., Nakamura, Ryotaro, Al Malki, Monzr M., Diamond, Don J., Dadwal, Sanjeet Singh, Forman, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Exceptional Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752192/
https://www.ncbi.nlm.nih.gov/pubmed/35008104
http://dx.doi.org/10.1182/bloodadvances.2021006282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752192/
https://www.ncbi.nlm.nih.gov/pubmed/35008104
http://dx.doi.org/10.1182/bloodadvances.2021006282

Ejemplares similares